RO-0506997

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRO-0506997
Drug Alias NameRO0506997A4I antagonist
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4 antagonists
TargetsIntegrin alpha-4
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[9] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A